Kidney Disease Clinical Trials

Showing 841-860 of 1,850 trials

NO_LONGER_AVAILABLE

Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)

NCT02051673

Four subjects were treated under compassionate use provisions under this study with facilitating cell therapy (FCRx)

Renal Failure

Talaris Therapeutics Inc.

Chicago, Illinois, United States

COMPLETEDPHASE4

Salivary Cortisol Measurement in Corticotrope Deficiency Substitution With Hydrocortisone.

NCT05457296

Patients with adrenal insufficiency are most often overdosed with hydrocortisone. To date, there is no reliable marker that can reflect the quality of hydrocortisone substitution. Salivary cortisol is a good reflection of free plasmatic cortisol. However, salivary contamination with the oral intake of hydrocortisone has been described. The aims of the study are to: * evaluate the frequency of salivary contamination by hydrocortisone taken in tablet form and determine its risk factors. * evaluate the quality of hydrocortisone substitution in patients with corticotrope deficiency.

Adrenal Insufficiency

University Tunis El Manar40 participantsStarted Jan 2021

Tunis, Tunisia • Tunis, Tunisia

COMPLETEDPHASE1/PHASE2

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

NCT01034631

The purpose of this study is to determine whether BNC105P in combination with/following everolimus is effective in the treatment of progressive metastatic clear cell renal cell carcinoma following prior tyrosine kinase inhibitors.

Renal Cell Carcinoma

Hoosier Cancer Research Network154 participantsStarted Jan 2010

Muscle Shoals, Alabama, United States • Hot Springs, Arkansas, United States • Burbank, California, United States +105 more locations

Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)

Salivary Cortisol Measurement in Corticotrope Deficiency Substitution With Hydrocortisone.

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Related Searches

Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer

Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia

42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

A Study to Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy Subjects

Pilot Study of Loop Diuretics Among Individuals Receiving Hemodialysis

Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis

End-Stage Kidney Disease Interactive Decision Aid for the Elderly (myKIDNEY)

Outcome of Glargine Insulin in Renal Impairment Patients With Diabetic Ketoacidosis

Relationship Between Serum 1,25-dihydroxy Vitamin D and Markers of Bone Metabolism in Renal Dysfunction Patients

Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101

Continuous Glucose Monitoring and Inflammation in Nondiabetic and Diabetic Patients Undergone Hemodialysis

Treatment of Obstructive Sleep Apnea in Chronic Kidney Disease

Metabolite Biomarkers Related to Acute Rejection in Kidney Transplantation

Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism

Kidney Precision Medicine Project

Effects of Green Propolis Extract (EPP-AF) on Inflammation in Hemodialysis Patients.

Desidustat in the Treatment of Chemotherapy Induced Anemia